Back
Pacific Biosciences of California Vs. Dyne Therapeutics Industry Stock Comparison
Buy
58
PACB
Pacific Biosciences of California
Last Price:
1.76
Seasonality Move:
38.23%
Sell
31
DYN
Dyne Therapeutics
Last Price:
33.84
Seasonality Move:
5.51%
Buy
58
Pacific Biosciences of California (PACB)
is a Buy
Is Pacific Biosciences of California a Buy, Sell or Hold?
- The current Pacific Biosciences of California [PACB] share price is $1.75. The Score for PACB is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- PACB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Dyne Therapeutics (DYN)
is a Sell
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $33.83. The Score for DYN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- DYN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PACB Stock Price Chart
What is Pacific Biosciences of California's stock price today?
-
The Pacific Biosciences of California share price today is $1.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PACB is experiencing selling pressure, which indicates risk of future bearish movement.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $33.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.
PACB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 52.47 | Buy |
Chaikin Money Flow: | -2869810 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.44 - 1.84) | Buy |
Bollinger Bands (100): | (1.45 - 1.95) | Buy |
DYN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.64 | Sell |
Relative Strength Index (14 RSI): | 40.26 | Sell |
Chaikin Money Flow: | -399891 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.67 - 41.65) | Sell |
Bollinger Bands (100): | (30.76 - 42.62) | Sell |
PACB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.79 | Sell |
20-day SMA: | 1.69 | Buy |
50-day SMA: | 1.67 | Buy |
200-day SMA: | 3.57 | Sell |
8-day EMA: | 1.75 | Buy |
20-day EMA: | 1.71 | Buy |
50-day EMA: | 1.7 | Buy |
200-day EMA: | 3.48 | Sell |
DYN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.84 | Sell |
20-day SMA: | 34.54 | Sell |
50-day SMA: | 40.17 | Sell |
200-day SMA: | 29.41 | Buy |
8-day EMA: | 34.53 | Sell |
20-day EMA: | 35.81 | Sell |
50-day EMA: | 37.51 | Sell |
200-day EMA: | 30.51 | Buy |
Pacific Biosciences of California Earnings Growth & PACB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.05 per share, an increase this year of $0.26 per share, and an increase next year of $0.22 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.82 per share, and a decrease next year of $0.01 per share.
Pacific Biosciences of California Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dyne Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |